{
    "id": "correct_subsidiary_00053_0",
    "rank": 42,
    "data": {
        "url": "https://www.onscope.com/ipowner/en/owner/ip/508209-ge-healthcare-ltd.html",
        "read_more_link": "",
        "language": "en",
        "title": "GE Healthcare Limited",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.onscope.com/ipowner/images/ipowner4.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/euipo2.png",
            "https://www.onscope.com/ipowner/images/tm1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/uspto2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/cipo2.png",
            "https://www.onscope.com/ipowner/images/patent1.png",
            "https://www.onscope.com/ipowner/images/wipo2.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "2.\n\nMODEL GENERATION APPARATUS FOR THERAPEUTIC PREDICTION AND ASSOCIATED METHODS AND MODELS\n\nApplication Number US2023020068 Publication Number 2023/212116 Status In Force Filing Date 2023-04-26 Publication Date 2023-11-02 Owner\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nVANDERBILT UNIVERSITY (USA)\n\nInventor\n\nWolber, Jan\n\nCsernai, Eszter Katalin\n\nKiss, Zoltán\n\nLippenszky, Levente\n\nOsterman, Travis\n\nPark, Ben Ho\n\nSmith, David Samuel\n\nFabbri, Daniel\n\nAbstract\n\nMethods, apparatus, systems, and articles of manufacture are disclosed for generation and application of models for therapeutic prediction and processing. A balance of precision and recall can be applied to at least one of a toxicity-related model or an efficacy-related model to configure immunotherapy treatment of a patient and/or cohort of patients. Model output can be evaluated differently depending on a determine patient selection criterion to trigger different actions.\n\nIPC Classes ?\n\nG16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires\n\nG16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients\n\nG16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems\n\nG16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders\n\n3.\n\nAPPARATUS, METHODS, AND MODELS FOR THERAPEUTIC PREDICTION\n\nApplication Number US2022032075 Publication Number 2023/211475 Status In Force Filing Date 2022-06-03 Publication Date 2023-11-02 Owner\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nVANDERBILT UNIVERSITY (USA)\n\nInventor\n\nWolber, Jan\n\nCsernai, Eszter Katalin\n\nKiss, Zoltán\n\nLippenszky, Levente\n\nOsterman, Travis John\n\nPark, Ben Ho\n\nSmith, David Samuel\n\nFabbri, Daniel\n\nAbstract\n\nMethods, apparatus, systems, and articles of manufacture are disclosed for generation and application of models for therapeutic prediction and processing. An example apparatus includes a plurality of models to predict at least one of a) a toxicity in response to immunotherapy or b) an efficacy of the immunotherapy, the plurality of models trained and validated using data from previous patients; and processor circuitry. The processor circuitry is to execute the instructions to: accept an input, via an interface, of data associated with a first patient; generate, using at least one of the plurality of models, a prediction of at least one of: a) a toxicity occurring during immunotherapy according to a treatment plan for the first patient or b) an efficacy of the immunotherapy treatment plan for the first patient; and output a recommendation for the first patient with respect to the treatment plan.\n\nIPC Classes ?\n\nG16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires\n\nG16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients\n\nG16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems\n\nG16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders\n\n4.\n\nMODEL GENERATION APPARATUS FOR THERAPEUTIC PREDICTION AND ASSOCIATED METHODS AND MODELS\n\nApplication Number US2022032084 Publication Number 2023/211476 Status In Force Filing Date 2022-06-03 Publication Date 2023-11-02 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nWolber, Jan\n\nCsernai, Eszter Katalin\n\nKiss, Zoltán\n\nLippenszky, Levente\n\nAbstract\n\nMethods, apparatus, systems, and articles of manufacture are disclosed for generation and application of models for therapeutic prediction and processing. An example apparatus includes processing circuitry to at least: process input data pulled from a record to form a set of candidate features; train a first model and a second model using the set of candidate features; test the first model and the second model to compare performance of the first model and the second model; select at least one of the first model or the second model based on the comparison; store the selected first model and/or second model; and deploy the selected first model and/or second model to predict a likelihood of at least one of: a) a toxicity occurring due to immunotherapy according to a treatment plan or b) efficacy of the treatment plan for a patient.\n\nIPC Classes ?\n\nG16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires\n\nG16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients\n\nG16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems\n\nG16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders\n\n6.\n\nELUENT SOLUTION\n\nApplication Number 17962686 Status Pending Filing Date 2022-10-10 First Publication Date 2023-03-02 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nWickstrom, Torild\n\nSvadberg, Anders\n\nHjelstuen, Ole Kristian\n\nEvje, Dag M.\n\nOchsenfeld, Liane\n\nAbstract\n\nThe present invention provides a novel method for the preparation of 18F-fluoride (18F) for use in radiofluorination reactions. The method of the invention finds use especially in the preparation of 18F-labelled positron emission tomography (PET) tracers. The method of the invention is particularly advantageous where bulk solutions are prepared and stored in prefilled vials rather than being freshly prepared on the day of synthesis. Also provided by the present invention is a radiofluorination reaction which comprises the method of the invention, as well as a cassette for use in carrying out the method of the invention and/or the radiofluorination method of the invention on an automated radiosynthesis apparatus.\n\nIPC Classes ?\n\nA61K 47/12 - Carboxylic acids; Salts or anhydrides thereof\n\nC07B 59/00 - Introduction of isotopes of elements into organic compounds\n\nB01J 19/00 - Chemical, physical or physico-chemical processes in general; Their relevant apparatus\n\nC01B 9/08 - Fluorides\n\nC07C 51/363 - Preparation of carboxylic acids or their salts, halides, or anhydrides by reactions not involving formation of carboxyl groups by substitution of halogen atoms by other halogen atoms\n\nA61K 51/04 - Organic compounds\n\n7.\n\nAPPARATUS AND METHOD FOR SOLID PHASE EXTRACTION\n\nApplication Number 17786383 Status Pending Filing Date 2020-12-17 First Publication Date 2023-01-26 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nMcrobbie, Graeme Walter\n\nKhan, Imtiaz Ahmed\n\nShales, Jonathan Robert\n\nAbstract\n\nThe present invention provides a cassette for determining optimised solid phase extraction (SPE) purification conditions, wherein said cassette comprises: (i) a flowpath comprising a first end and a second end; and (ii) a plurality of valves oriented along said flowpath, wherein each of said plurality of valves is selectively fluidly connected to one of a number of components, wherein said components comprise: (a) 1-5 composition vials; (b) 1-3 SPE cartridges; (c) 4-10 solvent vials; (d) a water vial; and (e) a transfer line. The present invention provides a cassette for determining optimised solid phase extraction (SPE) purification conditions, wherein said cassette comprises: (i) a flowpath comprising a first end and a second end; and (ii) a plurality of valves oriented along said flowpath, wherein each of said plurality of valves is selectively fluidly connected to one of a number of components, wherein said components comprise: (a) 1-5 composition vials; (b) 1-3 SPE cartridges; (c) 4-10 solvent vials; (d) a water vial; and (e) a transfer line. The present invention also provides a method for determining optimised SPE purification conditions for a compound from a composition, the method comprising: (i) provision of a cassette as defined in any of claims 1 to 7; (ii) the cassette comprising a composition of the compound in said composition vial(s) or addition of such a composition to said crude reaction vial(s); (iii) passing an aliquot of said composition into each of said 1-3 SPE cartridges; (iv) passing a particular combination of aliquots of solvent from at least 4 of said 4-10 solvent vials into one or more of the SPE cartridges, wherein the solvent in each of said 4-10 solvent vials is either a different solvent or the same solvent at different concentration; (v) eluting the compound to be purified from the or each SPE cartridge; (vi) evaluating the eluted products of step (v); and (vii) determining the optimised purification conditions by comparing the eluted products of step (v) from each cartridge and each solvent.\n\nIPC Classes ?\n\nB01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers\n\n10.\n\nPREPARATION OF A PH-ADJUSTED ASCORBIC ACID SOLUTION\n\nApplication Number EP2022066481 Publication Number 2022/263592 Status In Force Filing Date 2022-06-16 Publication Date 2022-12-22 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nMcrobbie, Graeme\n\nEngell, Torgrim\n\nWikene, Kristine\n\nKhan, Imtiaz Ahmed\n\nGrigg, Julian\n\nJackson, Alexander\n\nClarke, Alan\n\nShales, Jonathan\n\nAbstract\n\nProvided is a method of preparing an aqueous ascorbic acid solution having a pH of 2.0 to 4.0, the method comprising: providing an initial aqueous solution of ascorbic acid and a base, wherein the initial solution has a pH of 5.0 to 8.0; and combining the initial solution with a second acid to obtain an ascorbic acid solution having a pH of 2.0 to 4.0. Also provided is the use of an aqueous ascorbic acid solution having a pH of 2.0 to 4.0 prepared by a described method as a radiostabiliser of a radio-labelled compound.\n\nIPC Classes ?\n\nA61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones\n\nA61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo\n\nA61K 9/00 - Medicinal preparations characterised by special physical form\n\nA61K 47/02 - Inorganic compounds\n\nA61K 47/08 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen\n\n12.\n\nASCORBIC ACID VIAL\n\nApplication Number EP2022066484 Publication Number 2022/263595 Status In Force Filing Date 2022-06-16 Publication Date 2022-12-22 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor Wikene, Kristine\n\nAbstract\n\nProvided is a method of preparing a vial containing an ascorbic acid solution, the method comprising: providing an aqueous solution of ascorbic acid and a base, wherein the solution has a pH of 5.0 to 8.0; degassing the solution with an inert gas; dispensing the solution into a vial; degassing the vial headspace with an inert gas; and sealing the vial. Also provided is a vial containing: an aqueous solution of ascorbic acid and a base, wherein the solution has a pH of 5.0 to 8.0; and an inert gas.\n\nIPC Classes ?\n\nA61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones\n\nA61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo\n\nA61K 9/00 - Medicinal preparations characterised by special physical form\n\nA61K 31/375 - Ascorbic acid, i.e. vitamin C; Salts thereof\n\nA61K 47/02 - Inorganic compounds\n\nA61K 9/08 - Solutions\n\n17.\n\nCONNECTOR FOR FLEXIBLE TUBING\n\nApplication Number 17628518 Status Pending Filing Date 2020-08-05 First Publication Date 2022-09-01 Owner GE HEALTHCARE BIO-SCIENCES CORP. (USA) Inventor Sherman, Matthew\n\nAbstract\n\nA connector for flexible tubing, the connector comprising a hollow insert for allowing fluid flow, a first portion of the insert configured to fit inside the tubing, a second portion of the insert, the second portion having external threads, a sleeve configured to engage with the external threads of the second portion of the insert, by means of complementary internal threads, wherein said complementary threads are sized so as to threadingly engage with an outer surface of tubing fitted over said first portion of the insert and at the same time engage with the threads of the second portion of the insert.\n\nIPC Classes ?\n\nF16L 33/22 - Arrangements for connecting hoses to rigid members; Rigid hose-connectors, i.e. single members engaging both hoses with means not mentioned in the preceding groups for gripping the hose between inner and outer parts\n\n20.\n\nPURIFICATION METHOD AND COMPOSITIONS\n\nApplication Number 17314158 Status Pending Filing Date 2021-05-07 First Publication Date 2021-10-28 Owner GE Healthcare Limited (United Kingdom) Inventor\n\nEngell, Torgrim\n\nMeijer, Andreas\n\nKhan, Imtias Ahmed\n\nNairne, Robert James\n\nMcrobbie, Graeme\n\nAbstract\n\nThe present invention relates to the field of radiopharmaceuticals for in vivo imaging, in particular to a method of purifying a radiotracer which comprises 18F-labelled aminoxy-functionalised biological targeting moiety. The invention provides radioprotectant-containing radiopharmaceutical compositions of the tracers, as well as associated automated methods and cassettes.\n\nIPC Classes ?\n\nA61K 51/08 - Peptides, e.g. proteins\n\nC07B 63/00 - Purification; Separation specially adapted for the purpose of recovering organic compounds; Stabilisation; Use of additives\n\nC07B 59/00 - Introduction of isotopes of elements into organic compounds\n\nA61K 51/04 - Organic compounds\n\nA61K 51/12 - Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes\n\nB01D 15/20 - Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material\n\nB01D 15/22 - Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the construction of the column\n\nB01D 15/32 - Bonded phase chromatography, e.g. with normal bonded phase, reversed phase or hydrophobic interaction\n\nB01D 15/42 - Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution\n\nC07K 1/13 - Labelling of peptides\n\nC07K 1/14 - Extraction; Separation; Purification\n\nC07K 14/00 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof\n\n21.\n\nFluid processing based on inflatable bags, mixing system, and method of use thereof\n\nApplication Number 17353334 Grant Number 11918541 Status In Force Filing Date 2021-06-21 First Publication Date 2021-10-07 Grant Date 2024-03-05 Owner Biosafe S.A. (Switzerland) Inventor\n\nCamisani, Julien Pierre\n\nWaridel, Olivier\n\nAbstract\n\nA device and a method for mixing a fluid in a specimen bag is provided herein. In one embodiment, the device includes a mechanism for creating a first vortex and a second vortex. The first vortex is on a first side of a bag containing the fluid, and the second vortex is on a second side of the bag. The mechanism includes a first inflatable airbag and a second inflatable airbag. The first inflatable airbag is configured to create the first vortex when inflated and the second inflatable airbag is deflated. The second inflatable airbag is configured to create the second vortex when inflated and the first inflatable airbag is deflated.\n\nIPC Classes ?\n\nA61J 1/20 - Arrangements for transferring fluids, e.g. from vial to syringe\n\nA01N 1/02 - Preservation of living parts\n\nA61J 1/10 - Bag-type containers\n\nA61J 1/16 - Holders for containers\n\nA61M 1/02 - Blood transfusion apparatus\n\nB01F 25/42 - Static mixers in which the mixing is affected by moving the components jointly in changing directions, e.g. in tubes provided with baffles or obstructions\n\nB01F 31/55 - Mixers with shaking, oscillating, or vibrating mechanisms the materials to be mixed being contained in a flexible bag submitted to periodical deformation\n\nB01F 35/513 - Flexible receptacles, e.g. bags supported by rigid containers\n\nB01F 35/90 - Heating or cooling systems\n\nB01F 35/92 - Heating or cooling systems for heating the outside of the receptacle, e.g. heated jackets or burners\n\nB01F 101/23 - Mixing of laboratory samples e.g. in preparation of analysing or testing properties of materials\n\n26.\n\nAPPARATUS AND METHOD FOR SOLID PHASE EXTRACTION\n\nDocument Number 03165392 Status Pending Filing Date 2020-12-17 Open to Public Date 2021-06-24 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nMcrobbie, Graeme Walter\n\nKhan, Imtiaz Ahmed\n\nShales, Jonathan Robert\n\nAbstract\n\nThe present invention provides a cassette for determining optimised solid phase extraction (SPE) purification conditions, wherein said cassette comprises: (i) a flowpath comprising a first end and a second end; and (ii) a plurality of valves oriented along said flowpath, wherein each of said plurality of valves is selectively fluidly connected to one of a number of components, wherein said components comprise: (a) 1-5 composition vials; (b) 1-3 SPE cartridges; (c) 4-10 solvent vials; (d) a water vial; and (e) a transfer line. The present invention also provides a method for determining optimised SPE purification conditions for a compound from a composition, the method comprising: (i) provision of a cassette as defined in any of claims 1 to 7; (ii) the cassette comprising a composition of the compound in said composition vial(s) or addition of such a composition to said crude reaction vial(s); (iii) passing an aliquot of said composition into each of said 1-3 SPE cartridges; (iv) passing a particular combination of aliquots of solvent from at least 4 of said 4-10 solvent vials into one or more of the SPE cartridges, wherein the solvent in each of said 4-10 solvent vials is either a different solvent or the same solvent at different concentration; (v) eluting the compound to be purified from the or each SPE cartridge; (vi) evaluating the eluted products of step (v); and (vii) determining the optimised purification conditions by comparing the eluted products of step (v) from each cartridge and each solvent.\n\nIPC Classes ?\n\nC07B 59/00 - Introduction of isotopes of elements into organic compounds\n\n27.\n\nAPPARATUS AND METHOD FOR SOLID PHASE EXTRACTION\n\nApplication Number EP2020086901 Publication Number 2021/123073 Status In Force Filing Date 2020-12-17 Publication Date 2021-06-24 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nMcrobbie, Graeme, Walter\n\nKhan, Imtiaz, Ahmed\n\nShales, Jonathan, Robert\n\nAbstract\n\nThe present invention provides a cassette for determining optimised solid phase extraction (SPE) purification conditions, wherein said cassette comprises: (i) a flowpath comprising a first end and a second end; and (ii) a plurality of valves oriented along said flowpath, wherein each of said plurality of valves is selectively fluidly connected to one of a number of components, wherein said components comprise: (a) 1-5 composition vials; (b) 1-3 SPE cartridges; (c) 4-10 solvent vials; (d) a water vial; and (e) a transfer line. The present invention also provides a method for determining optimised SPE purification conditions for a compound from a composition, the method comprising: (i) provision of a cassette as defined in any of claims 1 to 7; (ii) the cassette comprising a composition of the compound in said composition vial(s) or addition of such a composition to said crude reaction vial(s); (iii) passing an aliquot of said composition into each of said 1-3 SPE cartridges; (iv) passing a particular combination of aliquots of solvent from at least 4 of said 4-10 solvent vials into one or more of the SPE cartridges, wherein the solvent in each of said 4-10 solvent vials is either a different solvent or the same solvent at different concentration; (v) eluting the compound to be purified from the or each SPE cartridge; (vi) evaluating the eluted products of step (v); and (vii) determining the optimised purification conditions by comparing the eluted products of step (v) from each cartridge and each solvent.\n\nIPC Classes ?\n\nC07B 59/00 - Introduction of isotopes of elements into organic compounds\n\n32.\n\nFormulation and method of synthesis\n\nApplication Number 16997188 Grant Number 11534494 Status In Force Filing Date 2020-08-19 First Publication Date 2021-02-04 Grant Date 2022-12-27 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nDyrstad, Knut Richard\n\nWickstrom, Torild\n\nRajanayagam, Thanushan\n\nRomoren, Kristine\n\nRyan, Olav\n\nAbstract\n\n18F-fluoride (18F) for use in radiofluorination reactions. The method of the invention finds use especially in the preparation of 18F-labelled positron emission tomography (PET) tracers. The method of the invention is particularly advantageous where bulk solutions are prepared and stored in prefilled vials rather than being freshly prepared on the day of synthesis. Also provided by the present invention is a radiofluorination reaction which comprises the method of the invention, as well as a cassette for use in carrying out the method of the invention and/or the radiofluorination method of the invention on an automated radiosynthesis apparatus.\n\nIPC Classes ?\n\nA61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo\n\nA61M 36/14 - Radioactive dressings\n\nA61K 47/12 - Carboxylic acids; Salts or anhydrides thereof\n\nA61K 51/04 - Organic compounds\n\n34.\n\nHEMODYNAMIC PARAMETER ESTIMATION BASED ON IMAGE DATA\n\nApplication Number EP2020070688 Publication Number 2021/013890 Status In Force Filing Date 2020-07-22 Publication Date 2021-01-28 Owner\n\nGE PRECISION HEALTHCARE LLC (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nZhao, Zhoushe\n\nNie, Yingbin\n\nZhang, Chen\n\nAbstract\n\nThe present approach relates to determining a reference value based on image data that includes a non-occluded vascular region (such as the ascending aorta in a cardiovascular context). This reference value is compared on a pixel-by pixel basis with the CT values observed in the other vasculature regions. With this in mind, and in a cardiovascular context, the determined FFR value for each pixel is the ratio of CT value in the vascular region of interest to the reference CT value.\n\nIPC Classes ?\n\nA61B 6/00 - Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment\n\nA61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging\n\n41.\n\nBioprocessing system\n\nApplication Number 16767403 Grant Number 11766508 Status In Force Filing Date 2018-12-06 First Publication Date 2020-11-26 Grant Date 2023-09-26 Owner Biosafe S.A. (Switzerland) Inventor\n\nCamisani, Julien\n\nMato Sabat, Pau\n\nAbstract\n\nDisclosed is a bioprocessing system comprising apparatus (200) including a centrifugal separation housing (210) having a temperature controllable compartment (215) for removably accepting a separation chamber (50), the apparatus further comprising at least one mixing station (250) for supporting one or more fluid storage vessels (10, 20, 30, 40), the station including a temperature controllable area (252) for increasing or decreasing the temperature of the contents of the or each supported vessel. The system further includes a disposable fluidic arrangement (100) including a centrifugal separation chamber (50) removably mountable within the compartment (215) and having one or more ports (52) allowing fluid ingress into, or egress out of the chamber, via the one or more ports in use, said ports being in fluid communication with one or more of said fluid storage vessels via fluid conduits (12, 22, 32, 42) and via one or more valve arrangement.\n\nIPC Classes ?\n\nA61M 1/02 - Blood transfusion apparatus\n\nB01D 21/26 - Separation of sediment aided by centrifugal force\n\nB01D 21/30 - Control equipment\n\nB01D 21/34 - Controlling the feed distribution; Controlling the liquid level\n\nB04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers\n\nB04B 15/02 - Other accessories for centrifuges for cooling, heating, or heat insulating\n\nB04B 13/00 - Control arrangements specially designed for centrifuges; Programme control of centrifuges\n\n42.\n\nSterile syringe comprising a non-sliding seal\n\nApplication Number 16758555 Grant Number 11541181 Status In Force Filing Date 2018-10-25 First Publication Date 2020-11-05 Grant Date 2023-01-03 Owner Biosafe S.A. (Switzerland) Inventor Mato Sabat, Pau\n\nAbstract\n\nThe invention discloses a sterile syringe (100) comprising a barrel (1) having internal surfaces (2), a plunger (3) movable within the barrel, a non-sliding seal (7) between the barrel and the plunger defining a sealed volume (8) and at least one filter (9) allowing only filtered gases to enter the sealed volume such that the syringe maintains its sterility even after several uses. The filters could be positioned on different locations on the syringe like on the non-sliding seal, the barrel, the barrel flange or the plunger handle.\n\nIPC Classes ?\n\nA61M 5/31 - Syringes - Details\n\nA61M 5/315 - Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod; Appliances on the rod for facilitating dosing\n\nA61L 2/20 - Gaseous substances, e.g. vapours\n\n45.\n\nCentrifugal separation chamber\n\nApplication Number 16641478 Grant Number 11712702 Status In Force Filing Date 2018-08-30 First Publication Date 2020-07-23 Grant Date 2023-08-01 Owner Biosafe S.A. (Switzerland) Inventor De Melo, Daniel\n\nAbstract\n\nDisclosed is a centrifugal separation chamber (100) rotatable about an axis (AR) and having a variable volume separation space (116) therewithin and a port (102) in fluid communication with the volume for filling and emptying the volume, the chamber including a relatively rigid portion (104) proximal to the port which has walls defining a part of the volume and arranged to provide reducing dimensions of the volume toward the port, the chamber further including a flexible portion (106) distal to the port for providing said variable volume, the flexible portion including a mechanical interface (110) for transmitting movement to the flexible portion to cause said variable volume.\n\nIPC Classes ?\n\nB04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers\n\nB04B 7/08 - Rotary bowls\n\n48.\n\nAUTOMATED IMAGE QUALITY CONTROL APPARATUS AND METHODS\n\nApplication Number EP2019086710 Publication Number 2020/136119 Status In Force Filing Date 2019-12-20 Publication Date 2020-07-02 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nFoley, Christopher, Peter\n\nMoreland, Jamie\n\nLászló, Ruskó\n\nTegzes, Pál\n\nAbstract\n\nAn image quality control system is disclosed. The example system includes an artificial intelligence modeler to process image data and metadata from patient data to generate first feature(s)from the image data and to parse the metadata to identify study information. The example system includes a computer vision processor to identify second feature(s)in the image data. The example system includes a results evaluator to compare the first feature(s)and second feature(s)to generate a comparison and to evaluate the comparison,first feature(s), and second feature(s)with respect to the study information to generate an evaluation. The example system includes a quality controller to compare the evaluation to quality criterion(-ia)to produce an approval or rejection of the patient data, the approval to trigger release of the patient data and the rejection to deny release of the patient data.\n\nIPC Classes ?\n\nG16H 30/00 - ICT specially adapted for the handling or processing of medical images\n\n49.\n\nAutomated image quality control apparatus and methods\n\nApplication Number 16233624 Grant Number 10984894 Status In Force Filing Date 2018-12-27 First Publication Date 2020-07-02 Grant Date 2021-04-20 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nFoley, Christopher\n\nTezges, Pal\n\nRusko, Laszlo\n\nAbstract\n\nAn image quality control system is disclosed. The example system includes an artificial intelligence modeler to process image data and metadata from patient data to generate first feature(s) from the image data and to parse the metadata to identify study information. The example system includes a computer vision processor to identify second feature(s) in the image data. The example system includes a results evaluator to compare the first feature(s) and second feature(s) to generate a comparison and to evaluate the comparison, first feature(s), and second feature(s) with respect to the study information to generate an evaluation. The example system includes a quality controller to compare the evaluation to quality criterion(-ia) to produce an approval or rejection of the patient data, the approval to trigger release of the patient data and the rejection to deny release of the patient data.\n\nIPC Classes ?\n\nG06K 9/00 - Methods or arrangements for reading or recognising printed or written characters or for recognising patterns, e.g. fingerprints\n\nG16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires\n\nG16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records\n\nG16H 30/20 - ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS\n\nG16H 30/40 - ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing\n\nG06T 7/00 - Image analysis\n\n51.\n\nIN-PROCESS DEVICE AND METHOD FOR CELL CULTURE MONITORING\n\nApplication Number EP2019086064 Publication Number 2020/127563 Status In Force Filing Date 2019-12-18 Publication Date 2020-06-25 Owner\n\nGLOBAL LIFE SCIENCES SOLUTIONS USA LLC (USA)\n\nGE HEALTHCARE UK LIMITED (United Kingdom)\n\nInventor\n\nPuranik, Swapnil\n\nRamakrishna, Manoj, Kumar\n\nPatiil, Haresh\n\nAbstract\n\nDisclosed is an in-process cell monitoring device comprising: a flow channel having at least one inlet and at least one outlet exposeable to a cell culture; a microscope positionable to view the contents of a region of the channel; and a computer operable at least to count any cells in the region, providing a closed fluid circuit for cell monitoring. Disclosed also is a bioreactor including a cell culture volume, and an in-process cell monitoring device, said device comprising: a flow channel having at least one inlet and at least one outlet each in fluid communication with the volume, of sufficient cross-sectional area to allow fluids to drain from the inlet to the outlet; and a microscope positionable to view the contents of a region of the channel, and also A method for monitoring a cell culture including determining cell density.\n\nIPC Classes ?\n\nG06K 9/00 - Methods or arrangements for reading or recognising printed or written characters or for recognising patterns, e.g. fingerprints\n\n53.\n\nRadiation source including osmium\n\nApplication Number 16791344 Grant Number 11670431 Status In Force Filing Date 2020-02-14 First Publication Date 2020-06-11 Grant Date 2023-06-06 Owner MEDI-PHYSICS, INC. (USA) Inventor\n\nButts, Matthew David\n\nShanks, Charles E.\n\nAbstract\n\nAn equatorial anthropic radiation source and a method of making an equatorial anthropic radiation source are described. The radiation source is useful in diagnostic imaging applications in healthcare or other industries (e.g. computerized three-dimensional segmental imaging; Crompton scattering imaging techniques; radiation detector check and calibration, in particular CdZnTe detectors commonly used in medical imaging).\n\nIPC Classes ?\n\nG21G 4/08 - Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical applications\n\nG21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes\n\nG21G 1/02 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes in nuclear reactors\n\nG21G 4/06 - Radioactive sources other than neutron sources characterised by constructional features\n\nG21G 1/06 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes outside of nuclear reactors or particle accelerators by neutron irradiation\n\nB29C 39/00 - Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor\n\nB29K 63/00 - Use of epoxy resins as moulding material\n\nB29K 505/08 - Transition metals\n\n54.\n\nDevice, system and method for the continuous processing and separation of biological fluids into components\n\nApplication Number 16708289 Grant Number 10773262 Status In Force Filing Date 2019-12-09 First Publication Date 2020-06-11 Grant Date 2020-09-15 Owner BIOSAFE S.A. (Switzerland) Inventor\n\nCamisani, Julien Pierre\n\nSublet, Yannick Andre\n\nMato Sabat, Pau\n\nAbstract\n\nA device for the processing and separation of biological fluids into components comprises a hollow centrifugal processing chamber (10) fitted with an inlet/outlet head (20) and preferably with an axially movable piston (18). The inlet/outlet head has two separate inlets/outlets, for instance an axial inlet (29) and a lateral outlet (40). The processing chamber (1) is fitted with an internal flow guide (30) enabling operation of the device in a continuous processing mode wherein biological fluid to be processed is continuously intaken by say the axial inlet (29) and at the same time processed components are continuously removed via say the lateral outlet (40). The continuous processing flow can be driven by an external peristaltic pump (59) and/or by axial displacement of a piston (18) in the chamber (10).\n\nIPC Classes ?\n\nB04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers\n\nA61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation\n\nB04B 11/02 - Continuous feeding or discharging; Control arrangements therefor\n\nB04B 11/06 - Arrangement of distributors or collectors in centrifuges\n\n56.\n\nAPPARATUS, SYSTEM AND METHOD FOR BIOPROCESSING\n\nApplication Number EP2019080904 Publication Number 2020/099342 Status In Force Filing Date 2019-11-11 Publication Date 2020-05-22 Owner\n\nGLOBAL LIFE SCIENCES SOLUTIONS USA LLC (USA)\n\nGE HEALTHCARE UK LIMITED (United Kingdom)\n\nInventor\n\nSmith, Reginald, Donovan\n\nZhang, Chengkun\n\nConway, Kenneth, Roger\n\nCastle, Jason\n\nAbstract\n\nA bioreactor vessel includes a body having upper and lower ends and a hollow interior cavity formed in the body, the interior cavity located between the upper and lower ends, the interior cavity being configured to receive biomaterials for processing. The interior cavity includes a lower boundary that is angled toward the lower end of the body such that the vessel may be tilted to allow biomaterials within the interior cavity to be extracted and concentrated and/or washed without the need for a separate bioprocessing device.\n\nIPC Classes ?\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\nC12M 3/06 - Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means\n\n57.\n\nSYSTEMS AND METHODS FOR DISTRIBUTED LEDGER MANAGEMENT OF NUCLEAR MEDICINE PRODUCTS\n\nApplication Number EP2019080613 Publication Number 2020/094814 Status In Force Filing Date 2019-11-07 Publication Date 2020-05-14 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nWolber, Jan\n\nLagona, Scott, W\n\nAbstract\n\nSystems and methods for tracking and management of a distributed ledger including information for a batch of radiopharmaceutical material are disclosed. Certain examples provide a computer-implemented method of managing radiopharmaceutical material including tracking, using at least one processor, a status of a batch of radiopharmaceutical material, the status to include a type, a quantity, and a timestamp associated with the batch of radiopharmaceutical material;generating a record in a first copy of a distributed ledger using the type, quantity, and timestamp associated with the batch of radiopharmaceutical material;updating the record based on at least one of usage of the batch of radiopharmaceutical material, resale of at least a portion of the batch of radiopharmaceutical material, and decay of the batch of radiopharmaceutical material; and sharing the record with a second copy of the distributed ledger.\n\nIPC Classes ?\n\nG06Q 10/00 - Administration; Management\n\n58.\n\nApparatus, non-transitory computer-readable storage medium, and computer-implemented method for distributed ledger management of nuclear medicine products\n\nApplication Number 16183188 Grant Number 11615882 Status In Force Filing Date 2018-11-07 First Publication Date 2020-05-07 Grant Date 2023-03-28 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nWolber, Jan\n\nLagona, Scott\n\nAbstract\n\nSystems and methods for tracking and management of a distributed ledger including information for a batch of radiopharmaceutical material are disclosed. Certain examples provide a computer-implemented method of managing radiopharmaceutical material including tracking, using at least one processor, a status of a batch of radiopharmaceutical material, the status to include a type, a quantity, and a timestamp associated with the batch of radiopharmaceutical material; generating a record in a first copy of a distributed ledger using the type, quantity, and timestamp associated with the batch of radiopharmaceutical material; updating the record based on at least one of usage of the batch of radiopharmaceutical material, resale of at least a portion of the batch of radiopharmaceutical material, and decay of the batch of radiopharmaceutical material; and sharing the record with a second copy of the distributed ledger.\n\nIPC Classes ?\n\nG16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms\n\nG06Q 30/06 - Buying, selling or leasing transactions\n\nA61K 9/51 - Nanocapsules\n\nC40B 30/06 - Methods of screening libraries by measuring effects on living organisms, tissues or cells\n\nG06Q 10/08 - Logistics, e.g. warehousing, loading or distribution; Inventory or stock management\n\nG06Q 30/0601 - Electronic shopping [e-shopping]\n\nG06Q 10/087 - Inventory or stock management, e.g. order filling, procurement or balancing against orders\n\n59.\n\nIMPROVEMENTS IN AND RELATING TO POLYMER MEMBRANES\n\nApplication Number EP2019079895 Publication Number 2020/089421 Status In Force Filing Date 2019-10-31 Publication Date 2020-05-07 Owner GE HEALTHCARE UK LIMITED (United Kingdom) Inventor\n\nSwinburne, Stuart\n\nGebauer, Klaus\n\nAbstract\n\nDisclosed is a method for the production of a porous polymer membrane suitable for liquid filtration or analyte capture, comprising the steps of: providing a flowable composition (100) on a substrate (220) the composition including at least: photo-activatable monomer molecules, photo activation initiator molecules and photo- activation quencher molecules; providing one or more pulses (L) of laser light at at least one focal point in the composition of sufficient energy to locally polymerise the composition; moving the or each focal point relative to the previously polymerised composition in a continuous or stepwise predetermined manner to a multiplicity of further positions;and repeating the pulse(s) at those further positions such that a three dimensional matrix of the composition is polymerised leaving unpolymerized areas of a size equivalent to conventional polymer membrane pores.\n\nIPC Classes ?\n\nB01D 67/00 - Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus\n\nB01D 69/12 - Composite membranes; Ultra-thin membranes\n\n60.\n\nSTERILE PRODUCT INVENTORY AND INFORMATION CONTROL\n\nApplication Number EP2019079739 Publication Number 2020/089339 Status In Force Filing Date 2019-10-30 Publication Date 2020-05-07 Owner\n\nGLOBAL LIFE SCIENCES SOLUTIONS USA LLC (USA)\n\nGE HEALTHCARE UK LIMITED (United Kingdom)\n\nInventor Pizzi, Vincent\n\nAbstract\n\nApparatus, systems, and methods for tracking and management of bioprocess and/or other sterile product inventory are disclosed. An example apparatus includes: a communication interface to receive a message from a radiofrequency identification circuit associated with a product via an antenna at a location; a keycode verifier to verify a keycode from the message as authentic and associated with the product; a certificate generator to provide, when the keycode is verified, a certificate for the product, the certificate to be sent from a cloud-based server to a local computing device at the location to enable use of the product; an inventory predictor to predict, based on an identification of the product and usage information for the product and/or the location, an exhaustion of the product at the location; an output generator to trigger an order of the product when the exhaustion of the product at the location is predicted.\n\nIPC Classes ?\n\nG06Q 10/00 - Administration; Management\n\n63.\n\nClosed evaporation system\n\nApplication Number 16555484 Grant Number 11094424 Status In Force Filing Date 2019-08-29 First Publication Date 2020-02-06 Grant Date 2021-08-17 Owner GE HEALTHCARE LIMITED (United Kingdom) Inventor\n\nFranci, Xavier\n\nLignon, Steve\n\nLange, Audrey\n\nAbstract\n\nThe present invention provides a system for evaporating a radioactive fluid, a method for the synthesis of a radiolabelled compound including this system, and a cassette for the synthesis of a radiolabelled compound comprising this system. The present invention provides advantages over known methods for evaporation of a radioactive fluid as it reduces drastically the amount of radioactive gaseous chemicals that are released in the hot cell. It is gentler and more secure compared to the known process and provides access to radiosyntheic processes that may not been acceptable for safety reasons related to release of volatile radioactive gases during evaporation. In addition, the process yields are higher because the radioactive volatiles are labelled intermediate species.\n\nIPC Classes ?\n\nA61K 51/00 - Preparations containing radioactive substances for use in therapy or testing in vivo\n\nA61M 36/14 - Radioactive dressings\n\nG21F 9/08 - Processing by distillation\n\nG21G 4/08 - Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical applications\n\nC07H 19/06 - Pyrimidine radicals\n\nB01J 19/00 - Chemical, physical or physico-chemical processes in general; Their relevant apparatus\n\nC07B 59/00 - Introduction of isotopes of elements into organic compounds\n\nC07C 227/40 - Separation; Purification\n\nC07D 233/91 - Nitro radicals\n\nC07J 1/00 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane\n\nG21G 1/00 - Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation, or particle bombardment, e.g. producing radioactive isotopes\n\nB01D 1/30 - Accessories for evaporators\n\n64.\n\nSAMPLING DEVICE AND METHOD\n\nApplication Number EP2019068174 Publication Number 2020/008067 Status In Force Filing Date 2019-07-05 Publication Date 2020-01-09 Owner\n\nGE HEALTHCARE BIO-SCIENCES CORP. (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor Yasser, Ali\n\nAbstract\n\nDisclosed is a product and method for sampling cells from a bioreactor, for the purposes of determining the cell count or to remove a sample and retain sterility of the sample for quality control (QC) assessment during a cell expansion in a bioreactor using vacuum tubes in combination with a sampling manifold (1) comprising:a primary fluid conduit (2);a connection port (3) positioned at one end of said fluid conduit (2) comprising means (4) for selective fluid connection of the interior of said fluid conduit (2) to the interior of a sampling reservoir (5); and a plurality of sampling ports (6a-e) disposed along said fluid conduit (2); wherein each of said plurality of sampling ports(6a-e) comprises means (7a-e) for selective fluid connection with an outlet (8a-e) adapted to connect to means (9) to permit exclusively unidirectional fluid flow from said primary fluid conduit.\n\nIPC Classes ?\n\nC12M 1/26 - Inoculator or sampler\n\nC12M 1/32 - Inoculator or sampler multiple field or continuous type\n\nG01N 1/10 - Devices for withdrawing samples in the liquid or fluent state\n\n65.\n\nSequential processing of biological fluids\n\nApplication Number 16559443 Grant Number 10874778 Status In Force Filing Date 2019-09-03 First Publication Date 2019-12-26 Grant Date 2020-12-29 Owner BioSafe S.A. (Switzerland) Inventor\n\nCamisani, Julien\n\nLink, Oliver\n\nAbstract\n\nA process for the sequential processing of opaque and transparent biological fluids such as whole blood, apheresis blood, bone marrow blood, umbilical cord blood, buffy coat or cultured cells by processing steps in a hollow cylindrical centrifugal processing chamber (300) which is part of a disposable set. At least three different procedures selected from washing, incubation, transduction, separation, density gradient separation, dilution and volume adjustment are each carried out once or repeated a number of times according to a given processing profile in the processing chamber. Each procedure involves an input into the processing chamber, an operation in the processing chamber and an output from the processing chamber by displacement of a piston (310). The at least three different procedures are sequentially chained one after the other to constitute an overall sequential operation in the processing chamber and its disposable set. A first application is incubation for binding magnetic beads with human blood cells or stem cells. A second application is transduction by which foreign genetic material is inserted into human blood cells or stem cells by a virus. A third application is reconditioning biological fluids to achieve reproducible concentration and volumes of blood cells or stem cells.\n\nIPC Classes ?\n\nA61M 1/02 - Blood transfusion apparatus\n\nA61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation\n\nA01N 1/02 - Preservation of living parts\n\nA61K 35/14 - Blood; Artificial blood\n\nB04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers\n\n67.\n\nCORIOLIS FLOW METER WITH MULTIPLE ACTUATORS\n\nApplication Number EP2019060109 Publication Number 2019/206811 Status In Force Filing Date 2019-04-18 Publication Date 2019-10-31 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nLang, Philipp\n\nRuetten, Jens\n\nSeeley, Charles E\n\nAbstract\n\nA system comprising that includes a flow tube configured to provide a flow path through the flow tube. The system also includes a plurality of actuators distributed radially about the flow tube, wherein a first actuator of the plurality of actuators is configured to drive a first oscillation in a first plane and a second actuator of the plurality of actuators is configured to drive a second oscillation in a second plane. Further, the system includes a plurality of sensor sets disposed on the flow tube, wherein each sensor set comprises two or more sensors configured to sense the first oscillation, the second oscillation, or both.\n\nIPC Classes ?\n\nG01F 1/84 - Coriolis or gyroscopic mass flowmeters\n\n69.\n\nSTORAGE VIAL\n\nApplication Number US2019029171 Publication Number 2019/210086 Status In Force Filing Date 2019-04-25 Publication Date 2019-10-31 Owner GE HEALTHCARE BIO-SCIENCES CORP. (USA) Inventor\n\nSaukkonen, Hanna-Leena\n\nStankowski, Ralph\n\nChernokalskaya, Elena\n\nCard, Cory\n\nAbstract\n\nA storage vial (100, 200) may include a vial body (110, 210) having a first end (111, 211) and a second end (112, 212) and defining an internal volume (113, 213) configured to contain a biological material (B) therein, a first valve (120, 220) positioned at the first end of the vial body, a second valve (130, 230) positioned at the second end of the vial body, a first conduit connector (160, 260) positioned at the first end of the vial body, and a second conduit connector (170, 270) positioned at the second end of the vial body. The resulting construction may allow for closed system direct transfer of biological material from the storage vial to another vessel using aseptic techniques.\n\nIPC Classes ?\n\nB01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers\n\nA61J 1/20 - Arrangements for transferring fluids, e.g. from vial to syringe\n\n71.\n\nINFLATABLE BIOREACTOR AND METHOD OF USE\n\nApplication Number US2019029143 Publication Number 2019/210067 Status In Force Filing Date 2019-04-25 Publication Date 2019-10-31 Owner GE HEALTHCARE BIO-SCIENCES CORP. (USA) Inventor\n\nSaukkonen, Hanna-Leena\n\nStankowski, Ralph\n\nAbstract\n\nAn inflatable bioreactor (110, 210) may include one or more sheets joined to form a bag (111, 211) including a top sheet (118, 218) and a bottom sheet (119, 219) formed from the one or more sheets and being inflatable to provide an internal volume (117, 217) suitable for retaining a volume of culture liquid (10) during flow of the culture liquid resulting from a rocking motion (R) of the bag, and one or more perturbing protrusions (116, 116', 116'', 216) extending upwardly from the bottom sheet toward, but not as far as, the top sheet and extending transversely to, or obliquely to, a direction of wave motion (W) of the culture liquid. The resulting construction may provide improved flow for low initial volumes of the culture liquid in the bag.\n\nIPC Classes ?\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\nC12M 3/06 - Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means\n\n75.\n\nMETHOD AND DEVICE FOR COLLECTING, PRESERVING AND TRANSFERRING SAMPLES\n\nApplication Number EP2019050688 Publication Number 2019/185208 Status In Force Filing Date 2019-01-11 Publication Date 2019-10-03 Owner GE HEALTHCARE UK LIMITED (United Kingdom) Inventor\n\nLamerton, Kathryn, Louise\n\nNorey, Christopher, George\n\nAbstract\n\nThe present invention relates to a method for collecting a biological sample, such as a forensic sample, the method comprising the steps of a) providing a swab including a handle wherein one tip or end of the handle is coated with fibres, such as polyester fibres, to form an absorbent flocked head, wherein the head having a surface area of 3-80 mm2 and wherein the swab head fits into a 10-200 µl volume reaction well/tube; b) collecting a biological sample comprising nucleic acid on the head by contact between the head and the sample, c) subjecting the nucleic acid in the sample to nucleic acid (NA)amplification. The invention also relates to a collection swab for use is said method.\n\nIPC Classes ?\n\nB01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers\n\nA61F 13/38 - Swabs having a stick-type handle\n\nC12M 1/30 - Sampler being a swab\n\nG01N 1/02 - Devices for withdrawing samples\n\n80.\n\nMICROSCOPE STAGE AND STAGE MOVEMENT MECHANISM\n\nApplication Number EP2019057460 Publication Number 2019/180278 Status In Force Filing Date 2019-03-25 Publication Date 2019-09-26 Owner\n\nGE HEALTHCARE BIO-SCIENCES CORP. (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nFogelberg, John Tenny\n\nCooper, Jeremy\n\nAbstract\n\nDisclosed is a microscope stage translation mechanism (100) comprising: a drive (110) rigidly attached or attachable to a bed (105) which drive provides substantially linear motion of a drive element (114); a rocker (130) arranged for pivoting motion about pivot axis (A-A), said axis being stationary relative to said bed (105), the rocker having a first region (122) arranged to be directly engageable with the drive element (114), and a second region (124) distant, relative to the axis, from the first region (122); and a follower having a follower surface (134) arranged to be directly engageable with the second region (124) of the rocker, the follower (130) being attached or attachable to a vertically moveable part of the stage;the mechanism (100) being characterised in that the drive element (114) and the first region (122) have point contact at a first contact point (P) when engaged, and in that the second region (124) and the follower surface (134) also have point contact at a second contact point (P) when engaged.\n\nIPC Classes ?\n\nG02B 21/26 - Stages; Adjusting means therefor\n\n84.\n\nAPPARATUS FOR FLUID LINE MANAGEMENT IN A BIOPROCESSING SYSTEM\n\nApplication Number EP2019053206 Publication Number 2019/155027 Status In Force Filing Date 2019-02-08 Publication Date 2019-08-15 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE UK LIMITED (United Kingdom)\n\nInventor\n\nGriffin, Weston, B\n\nCorwin, Alex, D\n\nXiaohua, Zhang\n\nSmith, Reginald, Donovan\n\nZhen, Liu\n\nChengkun, Zhang\n\nKeskar, Vandana\n\nDavis, Brian Michael\n\nShaikh, Kashan\n\nAbstract\n\nIn an embodiment, a tubing module for a bioprocessing system includes a first tubing holder block configured to receive at least one pump tube and hold the at least one pump tube in position for selective engagement with a peristaltic pump, a second tubing holder block configured to receive a plurality of pinch valve tubes and hold each pinch valve tube of the plurality of pinch valve tubes in position for selective engagement with a respective actuator of a pinch valve array, and wherein the first tubing holder block and the second tubing holder block are interconnected.\n\nIPC Classes ?\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\n85.\n\nDISPOSABLE KIT FOR BIOPROCESSING\n\nApplication Number EP2019053208 Publication Number 2019/155029 Status In Force Filing Date 2019-02-08 Publication Date 2019-08-15 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nGriffin, Weston, B\n\nCorwin, Alex, D\n\nXiaohua, Zhang\n\nSmith, Reginald, Donovan\n\nZhen, Liu\n\nChengkun, Zhang\n\nKeskar, Vandana\n\nDavis, Brian Michael\n\nShaikh, Kashan\n\nAbstract\n\nA system for bioprocessing includes a tray having plurality of sidewalls and a bottom surface defining an interior compartment, and a generally open top, and an opening formed in the bottom surface of the tray, the opening having a perimeter. The perimeter of the opening is shaped and/or dimensioned such that a bioreactor vessel can be positioned above the opening and supported by the bottom surface of the tray while a portion of the bioreactor vessel is accessible through the opening in the bottom surface. The tray is receivable within a processing chamber such that the bed plate extends through the opening in the bottom surface of the tray to support the bioreactor vessel.\n\nIPC Classes ?\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\nC12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus\n\n86.\n\nBIOPROCESSING APPARATUS\n\nApplication Number EP2019053209 Publication Number 2019/155030 Status In Force Filing Date 2019-02-08 Publication Date 2019-08-15 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nGriffin, Weston, B\n\nCorwin, Alex D\n\nXiaohua, Zhang\n\nSmith, Reginald, Donovan\n\nZhen, Liu\n\nChengkun, Zhang\n\nKeskar, Vandana\n\nBrian, Michael Davis\n\nKashan, Shaikh A\n\nAbstract\n\nAn apparatus for bioprocessing includes a housing, a drawer receivable within the housing, the drawer including a plurality of sidewalls and a bottom defining a processing chamber, and a generally open top, the drawer being movable between a closed position in which the drawer is received within the housing, and an open position in which the drawer extends from the housing enabling access to the processing chamber through the open top, and at least one bed plate positioned within the processing chamber and configured to receive a bioreactor vessel.\n\nIPC Classes ?\n\nC12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus\n\nC12M 1/02 - Apparatus for enzymology or microbiology with heat exchange means\n\n87.\n\nBIOPROCESSING METHODS FOR CELL THERAPY\n\nApplication Number EP2019053207 Publication Number 2019/155028 Status In Force Filing Date 2019-02-08 Publication Date 2019-08-15 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nGriffin, Weston, B\n\nCorwin, Alex, D\n\nXiaohua, Zhang\n\nSmith, Reginald, Donovan\n\nZhen, Liu\n\nChengkun, Zhang\n\nKeskar, Vandana\n\nDavis, Brian Michael\n\nShaikh, Kashan\n\nAbstract\n\nA non-transitory computer readable medium includes instructions configured to adapt a controller to maintain a first target environment in a bioreactor vessel containing a population of cells for a first incubation period to produce a population of genetically modified cells from the population of cells, initiate a flow of media to the bioreactor vessel, maintain a second target environment in the bioreactor vessel for a second incubation period to produce an expanded population of genetically modified cells.\n\nIPC Classes ?\n\nC12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\nC12M 1/36 - Apparatus for enzymology or microbiology including condition or time responsive control, e.g. automatically controlled fermentors\n\nC12M 3/06 - Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means\n\n88.\n\nBIOPROCESSING METHODS FOR CELL THERAPY\n\nApplication Number EP2019053210 Publication Number 2019/155031 Status In Force Filing Date 2019-02-08 Publication Date 2019-08-15 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nGriffin, Weston, B\n\nCorwin, Alex, D\n\nXiaohua, Zhang\n\nSmith, Reginald, Donovan\n\nZhen, Liu\n\nChengkun, Zhang\n\nKeskar, Vandana\n\nDavis, Brian Michael\n\nShaikh, Kashan\n\nAbstract\n\nA bioprocessing method for cell therapy includes the steps of genetically modifying a population of cells in a bioreactor vessel to produce a population of genetically modified cells, and expanding the population of genetically modified cells within the bioreactor vessel to generate a number of genetically modified cells sufficient for one or more doses for use in a cell therapy treatment without removing the population of genetically modified cells from the bioreactor vessel.Cells are settled on a gas permeable, liquid impermeable membrane for expansion, and are resuspended when, or after, the desired cell density is reached.\n\nIPC Classes ?\n\nC12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\nC12M 1/34 - Measuring or testing with condition measuring or sensing means, e.g. colony counters\n\nC12M 1/42 - Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic wave\n\n89.\n\nSYSTEM AND METHOD FOR FLUID FLOW MANAGEMENT IN A BIOPROCESSING SYSTEM\n\nApplication Number EP2019053211 Publication Number 2019/155032 Status In Force Filing Date 2019-02-08 Publication Date 2019-08-15 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nGriffin, Weston, B\n\nCorwin, Alex, D\n\nXiaohua, Zhang\n\nSmith, Reginald, Donovan\n\nZhen, Liu\n\nChengkun, Zhang\n\nKeskar, Vandana\n\nDavis, Brian Michael\n\nShaikh, Kashan\n\nAbstract\n\nA bioprocessing system includes a first fluid assembly having a first fluid assembly line connected to a first port of a first bioreactor vessel though a first bioreactor line of a first bioreactor vessel, a second fluid assembly having a second fluid assembly line connected to a second port of the first bioreactor vessel through a second bioreactor line of the first bioreactor vessel, and an interconnect line providing for fluid communication between the first fluid assembly and the second fluid assembly, and for fluid communication between the second bioreactor line of the first bioreactor vessel and the first bioreactor line of the first bioreactor vessel.\n\nIPC Classes ?\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\n91.\n\nIMPROVEMENTS IN AND RELATING TO BIOLOGICAL SAMPLE RECEIVERS\n\nApplication Number EP2019050599 Publication Number 2019/149501 Status In Force Filing Date 2019-01-10 Publication Date 2019-08-08 Owner GE HEALTHCARE UK LIMITED (United Kingdom) Inventor\n\nPatterson, Anthony, Richard\n\nWilliams, Anthony, Carl\n\nSlater, Paul\n\nAbstract\n\nDisclosed is a biological sample receiver (100) comprising: a planar substrate (10) for receiving a biological sample including a surface area (11) for accepting a biological sample; an envelope (25) substantially surrounding the substrate, said envelope including an opening (34) for facilitating the deposit of a biological sample onto said surface area (11); and a protective cover (40,50,60) formed around the envelope said protective cover including a closure panel (60) moveable at least to a first position where the opening (34) of the envelope is at least partially concealed, and to a second position where the opening (34) is exposed at least sufficiently to allow said deposit, the protective cover (40,50,60) being arranged further to allow the slidable separation of the envelope from the cover; the device being characterised in that said envelope and said cover are formed from a single sheet (15) of folded material.\n\nIPC Classes ?\n\nB01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers\n\nA61B 10/00 - Other methods or instruments for diagnosis, e.g. for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements\n\nG01N 1/00 - Sampling; Preparing specimens for investigation\n\n92.\n\nMETHOD AND KIT FOR VIRAL VECTOR ISOLATION\n\nApplication Number EP2018086202 Publication Number 2019/129643 Status In Force Filing Date 2018-12-20 Publication Date 2019-07-04 Owner\n\nGE HEALTHCARE BIO-SCIENCES CORP. (USA)\n\nGE HEALTHCARE BIO-SCIENCES AB (Sweden)\n\nInventor Smith, Trevor\n\nAbstract\n\nThe present invention relates to a method for purification of viral vectors, more closely it relates to purification of viral vectors from producer cells by using a single automated process. The method comprises the following steps: a) adding producer cells and cell lysis buffer to a processing container; b) mixing said producer cells and cell lysis buffer in said processing container to obtain a mixture; c) flowing said mixture through a chromatography column for purification of viral vectors, wherein the viral vectors are adsorbed on said chromatography column; and d) eluting viral vectors from the chromatography column into a product container.\n\nIPC Classes ?\n\nC12N 15/86 - Viral vectors\n\nC12N 7/00 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof\n\nC12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\n93.\n\nPROBE ASSEMBLY AND METHOD FOR SECURING AND INSERTING A PROBE\n\nApplication Number EP2018085817 Publication Number 2019/129570 Status In Force Filing Date 2018-12-19 Publication Date 2019-07-04 Owner\n\nGE HEALTHCARE BIO-SCIENCES CORP. (USA)\n\nGE HEALTHCARE BIO-SCIENCES AB (Sweden)\n\nInventor Ouellette, Matthew\n\nAbstract\n\nA probe assembly for inserting a probe into a vessel or tubing includes a probe sheath having a proximal end and a distal end and being configured for operative coupling to a vessel or tubing, the probe sheath being configured to receive a probe and to permit movement of the probe towards the distal end of the probe sheath, and a locking mechanism configured to restrain longitudinal movement of the probe with respect to the sheath in a locked state. The locking mechanism may be unlocked to allow for movement of the probe with respect to the sheath.\n\nIPC Classes ?\n\nB01L 9/00 - Supporting devices; Holding devices\n\nC12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\n94.\n\nMETHOD, APPARATUS, SYSTEM AND COMPUTER PROGRAM PRODUCT RELATING TO FILTRATION PROCESS\n\nApplication Number EP2018085322 Publication Number 2019/121573 Status In Force Filing Date 2018-12-17 Publication Date 2019-06-27 Owner\n\nGENERAL ELECTRIC COMPANY (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nRamakrishna, Manoj, Kumar\n\nPuranik, Swapnil\n\nKhan, Mohammed Mehtab\n\nAbstract\n\nMethods for selecting a filter for a filtration process are described. Input data is received, and based on the input data, one or more filter characteristics for each of a plurality of filter candidates for a filtration process are identified. Process parameters of the filtration process are identified. A computer-implemented simulation process of the filtration process for each of the plurality of filter candidates is performed, based on the identified process parameters and identified filter characteristics. One or more output characteristics of the filtration process are determined based on the simulation. A filter candidate of the plurality of filter candidates is selected based on the one or more output characteristics.\n\nIPC Classes ?\n\nG06F 17/50 - Computer-aided design\n\n96.\n\nA FLUID PORT\n\nApplication Number EP2018085066 Publication Number 2019/121424 Status In Force Filing Date 2018-12-14 Publication Date 2019-06-27 Owner\n\nGE HEALTHCARE BIO-SCIENCES CORP. (USA)\n\nGE HEALTHCARE LIMITED (United Kingdom)\n\nInventor\n\nFraser, Donald, M\n\nAli, Yasser\n\nWecharatana, Mathew\n\nBrueggeman, James\n\nAbstract\n\nThe present invention relates to a flexible bag, a perfusion filter and a fluid port. The fluid port comprises: - a first fluid connection (3; 3'); - a second fluid connection (5; 5') being in fluid communication with the first fluid connection (3; 3'); - an intermediate fluid path (7: 7') connecting the first fluid connection (3; 3') with the second fluid connection (5; 5'); wherein said intermediate fluid path (7; 7') at least a portion of which comprises a substantially right-angled bend (9; 9'); - a protection cap (11; 11') protecting at least the bend (9; 9') of the intermediate fluid part (7; 7') from contact with other objects; and - a connection surface (13; 13') configured for sealing to a film of an object to be supplied by said port, said connection surface will, when sealed to the film of the object, together with the film provide a fluid tight seal surrounding the first fluid connection (3; 3').\n\nIPC Classes ?\n\nC12M 1/00 - Apparatus for enzymology or microbiology\n\nC12M 3/06 - Tissue, human, animal or plant cell, or virus culture apparatus with filtration, ultrafiltration, inverse osmosis or dialysis means\n\n99.\n\nA BIOPROCESSING SYSTEM\n\nDocument Number 03084566 Status Pending Filing Date 2018-12-06 Open to Public Date 2019-06-13 Owner BIOSAFE S.A. (Switzerland) Inventor\n\nCamisani, Julien\n\nMato Sabat, Pau\n\nAbstract\n\nDisclosed is a bioprocessing system comprising apparatus (200) including a centrifugal separation housing (210) having a temperature controllable compartment (215) for removably accepting a separation chamber (50), the apparatus further comprising at least one mixing station (250) for supporting one or more fluid storage vessels (10, 20, 30, 40), the station including a temperature controllable area (252) for increasing or decreasing the temperature of the contents of the or each supported vessel. The system further includes a disposable fluidic arrangement (100) including a centrifugal separation chamber (50) removably mountable within the compartment (215) and having one or more ports (52) allowing fluid ingress into, or egress out of the chamber, via the one or more ports in use, said ports being in fluid communication with one or more of said fluid storage vessels via fluid conduits (12,22,32,42) and via one or more valve arrangements\n\nIPC Classes ?\n\nA61M 1/36 - Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation\n\nA61M 1/02 - Blood transfusion apparatus\n\nB04B 5/04 - Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers\n\nB04B 15/02 - Other accessories for centrifuges for cooling, heating, or heat insulating"
    }
}